STAT6 and acute lymphoblastic leukemia: As a step towards this end, we herein first found that relapsed ALL specimens exhibit a substantially lower STAT6 expression compared with their paired diagnosis specimens; this differs from previous studies, which showed a high expression of STAT6 in various tumors and its association with tumorigenesis and poor prognosis in human cancers [26, 30–32].